Objectives Congenital heart defects (CHDs) are reported to be associated with a smaller fetal head circumference (HC) 
INTRODUCTION
Severe congenital heart defects (CHDs) occur in 2-3/1000 livebirths and are responsible for significant morbidity and mortality. New methods of neonatal support and advanced surgical techniques have improved the survival rate significantly over the last decades. As a result, the focus of attention has shifted from survival to irreversible morbidity and long-term outcome 1 . Children with a severe CHD frequently show cerebral impairments and neurodevelopmental delay (ND) 2 -4 . Major causes of ND are hypoxia, thromboembolic insults and other surgical factors 5 -8 . However, more than 50% of newborns with a CHD have signs of neurological abnormalities prior to surgery, raising the question of whether CHDs might cause prenatal cerebral damage 9 -11 . It has been hypothesized that intrauterine hypoxic central nervous system damage or altered cerebral arterial hemodynamics induces delayed brain maturation and growth 12 -16 . Various studies have found significantly smaller head circumference (HC) in non-syndromic CHDs, mainly in children with transposition of the great arteries (TGA), tetralogy of Fallot (ToF) and hypoplastic left heart syndrome (HLHS) 17 -20 . However, the published cohorts attempting to validate the prenatal hemodynamics hypothesis are small and focus only on specifically severe CHDs 12 -16,21,22 . If the HC is smaller at birth, then the smaller HC should be detectable prior to birth. If cerebral flow and oxygen delivery play an important role, the relationship between the type of CHD and the HC should be apparent. As the presence of reduced head growth might be associated with ND after birth 23 , its presence may be predictive and could impact on parental counseling. Few studies, however, have focused on prenatal head growth in fetuses with a CHD 13, 16, 23 -28 . Our aim was to evaluate patterns of HC growth in a large cohort of fetuses with various types of CHD, analyse these patterns according to the CHD type and estimate the effect of fetal cerebral hemodynamics (aortic arch flow and ascending aorta oxygen saturation) on HC growth during the second and third trimesters. We hypothesized that, in the presence of normal abdominal growth, HC growth is diminished in fetuses with a CHD with reduced ascending aorta oxygen saturation and/or reduced aortic arch flow.
METHODS
This study was performed in the Leiden University Medical Center (LUMC), VU Medical center and Amsterdam Medical Center over a 12.5-year period. These three university medical centers collaborate in the care of children with CHDs (Center for Congenital Heart Defects Amsterdam Leiden, CAHAL). All children with a CHD born between January 2002 and January 2012 were entered in the CAHAL database. The cases and methods of data collection have been described previously 29 . The CAHAL database was supplemented with consecutive CHD cases born in the LUMC between January 2012 and July 2014. From this combined database, fetuses with prenatally diagnosed structural CHDs were extracted. Functional CHDs, such as cardiomyopathy and primary arrhythmias, were not eligible for inclusion. Cases with coexisting significant extracardiac malformations, severe hydrops, genetic anomalies and/or postnatally appearing syndromal abnormalities were excluded from further analysis. Minor additional findings, such as soft markers (e.g. echogenic focus and echogenic bowel), amniotic fluid pathology, mild pericardial effusion and/or single umbilical artery were not considered as significant extracardiac abnormalities and were not excluded. Multiple pregnancy, as well as cases with maternal pathology that could have an effect on fetal growth, i.e. pregnancy-induced hypertension, pre-eclampsia, HELLP syndrome or signs of placental insufficiency by postnatal placental weight examination, were excluded. Pre-and postnatal ultrasound data were reviewed. Postnatal follow-up regarding the definitive cardiac defect, genetic defects or syndromal diagnosis and neurodevelopment was acquired from clinical files, which were available until at least 1 year of age. Pre-existent maternal illnesses (such as pre-existent hypertension and thyroid disease), maternal smoking, body mass index (BMI) and parity were extracted from clinical files. Gestational age (GA) was based on the first-trimester ultrasound examination. Repeat prenatal ultrasound examinations were performed routinely to re-evaluate the cardiac defect and to assess fetal wellbeing. At each examination, fetal biometric data were measured routinely. Thus, head and abdominal circumference (HC and AC) were entered prospectively in patient files and extracted from the fetal ultrasound databases for the purpose of this study. The measurements were performed according to the guidelines of the Dutch Society for Obstetrics and Gynecology 30 , which are the same as those described by the International Society of Ultrasound in Obstetrics and Gynecology.
Clustering of CHDs
First, CHDs were defined according to the postnatal diagnosis, made by postnatal ultrasound or postmortem examination. Second, CHDs were clustered based on two aspects: oxygen delivery and flow to the brain. As an indication for oxygen delivery to the brain, the CHDs were clustered by ascending aorta oxygen saturation as having either: (1) low oxygen delivery to the brain (e.g. TGA); (2) intracardiac mixing of the oxygen-rich and oxygen-poor blood (e.g. atrioventricular septal defects, ToF); or (3) normal oxygen delivery to the brain (e.g. congenitally corrected TGA without additional cardiac defects, Ebstein's anomaly with normal cardiac function). As an indication for cerebral blood flow, CHDs were categorized as having either: (1) reversed aortic arch flow (e.g. aortic atresia, hypoplastic left heart syndrome (HLHS)); (2) obstructed aortic arch flow (e.g. aortic stenosis or hypoplasia); or (3) normal aortic arch flow (e.g. ToF, TGA). In some cases, clustering was complex; for instance, severe aortic stenosis (developing HLHS) can display forward flow in the aorta prenatally. For the subtypes of CHD in which the clustering was disputable, or in which the flow direction in the aorta was not described in the files, two researchers (F.A.R.J. and M.E.B.R.) re-evaluated independently all pre-and postnatal ultrasound and postmortem data to retrieve information about aortic arch flow and ascending aorta oxygen saturation in the prenatal period. In Appendix S1, the methods of clustering are clarified further and the types of CHD in the different clusters are listed. Our method of clustering shows similarities to the subclassification of Masoller et al. 28 and is based on theoretical hemodynamics. Actual in vivo measurement of cerebral oxygenation would be preferable 21 , but resources and expertise to do this are not widely available. Thus our approach is the most feasible and the most accessible for large groups, thereby minimizing selection bias.
Data handling and statistical analysis
All biometric data were compared with the growth charts of Verburg et al. 30 , because these growth charts were produced from a large comparable Dutch population (n = 3760) and constructed in approximately the same period as our own cohort, using modern ultrasound machines. HC and AC were converted into z-scores. The HC/AC ratio is not available in these growth charts. To account for the dependence between repeat measurements in the same fetus, we used a linear mixed-regression model to study the effect of increasing GA on the z-scores. First, we analyzed the z-scores in a univariate-regression model to assess the difference in biometry when compared with normal values and estimate the clinical relevance. Growth restriction of the fetal head was defined as a significant decrease in HC z-score with advancing GA (the slope of the regression). Secondary to this model, we compared separately the effect of increasing GA on the z-scores between fetuses clustered according to cerebral blood flow and according to ascending aorta oxygen saturation. Third, we used both clusterings, as well as known confounders, as covariates in a multivariate regression analysis. Variables of interest and confounders were only used as covariates if the univariate effect size was smaller than P = 0.1. Obesity was defined as a BMI > 25 kg/m 2 . The percentage of fetuses with HC below -2SD of the normal growth charts within subgroups were compared by the chi-square test. Statistical analysis was performed using IBM SPSS Statistics version 20.0.0 (IBM, Armonk, NY, USA); P < 0.05 was considered statistically significant. Data were displayed using Prism version 6.02 (GraphPad Software, La Jolla, CA, USA).
RESULTS
With the above-described criteria, we identified 1089 fetuses from the CAHAL database. Cases with significant genetic anomalies and/or postnatal appearing syndromal abnormalities (n = 254), extracardiac malformations/severe hydrops (n = 340), primary arrhythmia (n = 10), functional CHD (cardiomyopathy n = 9), multiple pregnancy (n = 18) or maternal pathology with possible effect on fetal growth (n = 22) were excluded. Therefore a total of 436 fetuses were eligible for inclusion, of which 306 (70%) were liveborn and in 121 (28%) cases the pregnancy was terminated. Postnatal confirmation of the CHD by ultrasound examination was available in 99% of liveborn cases. Postnatal confirmation of the CHD was possible in 42% of the demised fetuses; in 58% the parents did not give permission for postmortem examination. Loss to follow-up due to birth outside of The Data are given as n (%) or n. *See Appendix S1 for full list of types of CHD. BMI, body mass index.
Netherlands occurred in five cases. Basic characteristics of the group, such as parity, BMI, pre-existent maternal illness and the presence and type of minor additional findings, as well as the CHD diagnoses are summarized in Table 1 . In 290 fetuses, multiple biometric measurements were acquired (median number of available examinations, 4 (range, 2-11)) and in 146 fetuses only one measurement was acquired, resulting in a total of 1322 measurements between 12 + 5 and 40 + 5 weeks' gestation. The clustering of fetuses by aortic arch flow and ascending aorta oxygen saturation was possible in all included cases. The resulting clusters are depicted in Table 2 , with the corresponding number of fetuses in each cluster.
All CHDs combined
Compared with normal growth charts, the HC z-score of the whole CHD cohort decreased with advancing Data are given as n.
GA (slope of −0.017/day, univariate regression analysis, Table S1 ). The mean HC z-score was 0.02 (95% CI, −0.09 to 0.12) at 20 weeks of gestation, reducing to −0.23 (95% CI, −0.35 to −0.11) at 36 weeks of gestation. An HC below -2SD at any point in pregnancy was encountered in 8.0% (n = 35/436) of fetuses (Table S2) . True microcephaly, defined as an HC below -3SD, in the presence of normal overall fetal growth 31 , was not identified in our cohort.
Specific cardiac defects
The results of univariate regression analyses of HC z-score in specific types of CHD compared with normal growth charts are shown in Figure 1 and Table S1 . Fetuses with TGA showed normal HC z-score at 20 weeks of gestation (−0.14 (95% CI, −0.44 to 0.16)) but statistically significant HC growth restriction with advancing GA (HC z-score at 36 weeks of gestation of −0.35 (95% CI, −0.63 to −0.07)). Fetuses with isolated ToF showed a smaller HC z-score at 20 weeks of gestation (−0.67 (95% CI, −1.16 to −0.18) but changes in HC z-score with advancing GA were not statistically significant. No statistically significant differences compared with normal growth charts were found in fetuses with HLHS (n = 76), Ebstein's anomaly (n = 12), tricuspid atresia (n = 16), persistent left superior vena cava (PLSVC) without left ventricle obstruction (n = 15), coarctation of the aorta (n = 20) or ventricular septal defect (n = 28), when analyzed separately. The other types of CHD (all n < 12) were not analyzed separately because numbers were too small to perform a reliable regression analysis.
In the combined group of CHD with normal brain oxygenation and normal aortic flow (such as rhabdomyomata (without tuberous sclerosis), congenitally corrected TGA, Ebstein's anomaly without hydrops and PLSVC without left ventricle inflow obstruction), we found a statistically significantly higher mean HC z-score at 20 weeks of gestation compared with the mean of the normal population (0.31 (95% CI, 0.08 to 0.53)), but there was a significant decrease in HC growth with advancing GA (slope of −0.024, Table S1 ). , hypoplastic left heart syndrome;
, transposition of the great arteries; , Ebstein's anomaly; , tricuspid atresia; , coarctation of the aorta;
, ventricular septal defect; , tetralogy of Fallot. p, percentile.
Ascending aorta oxygen saturation

Intergroup analysis
We observed a lower mean HC z-score (−0.47 (95% CI, −0.88 to −0.06)) in the low-oxygen saturation (TGA) group and the group with intracardiac mixing of oxygen-rich and oxygen-poor blood (intracardiac-mixing group) (−0.41 (95% CI, −0.64 to −0.17)) when compared with the normal-oxygen saturation group (reference value) at a GA of 20 weeks (Table 3 and Figure 2 ). There were no statistically significant differences in HC growth between the low-, mixedand normal-ascending aorta oxygen saturation groups, although the low-oxygen (TGA) group tended to have a slightly shallower slope.
Comparison with growth curves of normal population
Compared with the normal growth charts, fetuses with low or reduced ascending aorta oxygen saturation (clusters of TGA and intracardiac mixing) did not have a significantly smaller HC z-score at 20 weeks of gestation (Table S1 , TGA, −0.14 (95% CI, −0.44 to 0.16); intracardiac mixing, −0.11 (95% CI, −0.25 to 0.03)). At 36 weeks of gestation, however, both groups displayed a significantly lower HC z-score when compared with normal fetuses (TGA, −0.35 (95% CI, −0.63 to −0.07); intracardiac mixing, −0.33 (95% CI, −0.50 to −0.17)). There were no significant differences in the percentages of fetuses with an HC below -2SD of the normal population between the groups (Table S2) , which was observed at any point in pregnancy in 5.3% of fetuses with TGA, in 9.6% with intracardiac mixing and in 5.8% with normal oxygen saturation. 
Figure 2
Influence of ascending aorta oxygen saturation on head circumference (HC) z-score throughout pregnancy, compared with normal growth charts 30 , in fetuses with prenatally detected isolated congenital heart defects. Plots shown relative to normal 95% range (a) and magnified version with 95% CIs (gray lines) (b). , normal ascending aorta oxygen saturation; , low ascending aorta oxygen saturation (TGA);
, intracardiac mixing.
Aortic arch flow
Intergroup analysis
Compared with the group of fetuses with normal aortic arch flow, the mean HC z-score at 20 weeks of gestation tended to be slightly lower in the group with reversed aortic arch flow (HLHS fetuses), but the difference was not statistically significant (Table 3 and Figure 3 ). There were no significant differences in the slope of HC growth during gestation between all subgroups of aortic arch flow. Of the cases with HLHS (reversed flow), termination of pregnancy was performed in 65%, resulting in 26 cases included in the regression analysis in this subgroup.
Comparison with growth curves of a normal population
Compared with the normal growth charts, fetuses with reversed aortic arch flow tended to have a smaller HC at 20 weeks of gestation (−0.20 (95% CI, −0.44 to 0.04)) and fetuses with obstructed aortic arch flow tended to have a slightly larger HC (0.14 (95% CI, −0.12 to 0.40)); however, these differences were non-significant (Table S1 ). At 36 weeks of gestation, fetuses with normal aortic arch flow had a significantly smaller HC z-score (−0.26 (95% CI, −0.41 to −0.12)) when compared with normal growth charts. Although an HC below -2SD was observed at any point in pregnancy in 9.2% of HLHS fetuses (reversed aortic arch flow) in our cohort 30 , in fetuses with prenatally detected isolated congenital heart defects. Plots shown relative to normal 95% range (a) and magnified version with 95% CIs (gray lines) (b).
, normal flow; , obstructed flow; , reversed flow (HLHS). (Table S2) , there were no significant differences in the percentage of fetuses with an HC below -2SD between those with normal and abnormal aortic arch flow. An HC below -2SD at any point in pregnancy was also observed in 8.6% of fetuses with normal aortic arch flow and in 5.0% of fetuses with obstructed aortic arch flow.
Confounders and multivariate analysis
Besides the variables of interest, the influence of possible confounders, such as parity and smoking, is displayed in Table 3 in a univariate analysis. Cases in which the pregnancy was terminated and fetuses from nulliparous women showed a significantly smaller HC at mid-gestation. Maternal obesity resulted in larger HC with advancing GA. Variables of interest and possible confounders that were used as covariates in a multivariate linear mixed regression model are indicated in Table 3 . In the multivariate model (Table 4) , no statistically significant influence of ascending aorta oxygen saturation and aortic arch flow on the mid-gestational HC z-score was found. Of the possible confounders, only BMI > 25 kg/m 2 remained significantly correlated with increasing HC growth (slope).
Abdominal circumference
The AC z-score regression analysis in the overall cohort of fetuses with CHD is summarized in Table S3 . The mean AC z-score was −0.05 (95% CI, −0.15 to 0.06) at 20 weeks of gestation, with a slight, but not significant, increase to a mean of 0.11 (95% CI, −0.02 to 0.24) at 36 weeks of gestation. Clustering of the cases according to ascending aorta oxygen saturation or aortic arch flow had no effect on the mean AC z-score at 20 weeks of gestation or on the slope of AC z-score with advancing GA (data not shown).
DISCUSSION
This study shows that all fetuses with a prenatally detected isolated CHD show a decline in HC growth Table 4 Multivariate effect estimations of influence of variables on mid-trimester head circumference (HC) z-score in fetuses with prenatally detected congenital heart defects (CHD)
Variable
Influence on HC z-score (95% CI Type III tests of fixed effects and estimates; dependent variable: HC z-score compared with normal growth charts 30 . *Statistically significant. †Other variables, besides obesity, with possible effect on advancing gestational age were not included in multivariate analysis because univariate effect size was > P = 0.1. HLHS, hypoplastic left heart syndrome; IUFD, intrauterine fetal demise; TGA, transposition of the great arteries; TOP, termination of pregnancy.
with advancing GA, irrespective of aortic flow or oxygen saturation. However, the clinical relevance of this decrease is small, as the effect size compared with the HC growth charts of normal populations is small (mean HC z-score in all types of CHD combined was −0.23 at 36 weeks of gestation, corresponding to the 41 st percentile). The most important finding of this study is that differences in HC z-score growth slopes between the various CHD clusters were absent. Interestingly, fetuses with normal aortic flow and oxygen saturation (such as in Ebstein's anomaly, persistent left caval vein and ventricular septal defects (VSDs)) showed the same decline in HC growth as in fetuses with obstructed or reversed flow (such as HLHS) or with low oxygen saturation or intracardiac mixing (such as TGA and ToF).
Our study confirms the reported smaller HC at birth in infants with a severe CHD 17 -20 , and a recent large population-based study also reported smaller neonatal HC in less severe types of CHD 32 . Our data indicate that fetuses with ToF present with a smaller HC, which is already present at mid-gestation (z-score of −0.67, corresponding to the 25 th percentile). A mid-gestational smaller HC was not evidently present in fetuses with reversed flow in the aortic arch (HLHS) and TGA, nor in the other types of CHD in our cohort.
Strengths of our cohort are the consecutive, non-selective inclusion of all cases with prenatally identified CHDs in three centers. The repeated measurements facilitated the linear regression analysis of prenatal growth, from 20 weeks of gestation until birth. The size of the cohort made it possible to analyze prenatally specific types of CHD for the first time. Our clustering into various subgroups is highly accurate due to high rates of postnatal or postmortem confirmation.
Our study demonstrates fetal growth patterns in isolated CHDs, irrespective of the severity of the defect. Until now, only nine studies have assessed fetal biometrics, all with different case mixes, various methods of subclassification and heterogeneous findings 13,16,23 -28,33 . Most authors reported smaller HC at mid-gestation 23, 27, 28 or in the third trimester 16, 24, 27, 33 . Subtypes of CHD such as TGA and ToF are rarely reported separately, and less severe CHDs have never been reported solely. The differences with our study can be explained by the fact that reports might have included preselected, non-consecutive, severe CHD cases and were dominated by specific CHDs, such as ToF. Some reports may not have excluded all intrauterine growth restricted cases and follow-up after birth was not always available. Three of the studies focused on cohorts of fetuses with (developing) HLHS only 13, 23, 26 . In an MRI study of 18 fetuses with HLHS, delay in cerebral development and volume growth was noted in the third trimester, hypothesized to precede HC growth restriction 34 . Our study comprises the largest cohort of consecutive HLHS cases so far (n = 76). We found a smaller HC at mid-gestation in fetuses with HLHS, but statistical significance was absent. The HC growth restriction with advancing GA (slope) appeared even less severe compared with other types of CHD.
Our findings underline the uncertainty regarding the etiology of the smaller HC in fetuses with CHD. A direct relationship between aortic flow or oxygen saturation and small HC could not be established clearly. Our results point towards an influence of type of CHD on HC growth, but sample sizes are nonetheless too small to establish a direct relationship. We postulate that the smaller HC in certain types of CHD may be caused by certain genetic or embryological developmental pathways. CHDs develop through multifactorial pathways 35, 36 and some of these factors might also influence fetal HC growth and brain development 26, 30 . By excluding known genetic syndromes by postnatal examination or standard antenatal genetic analysis in our study, this influence has been corrected maximally. We are, however, limited by the discriminating power of the diagnostic methods used.
Placental dysfunction and smaller fetal weight could also play a role in the smaller HC in fetuses with an isolated CHD. Suggestions for this mechanism have also been found by Sun et al., who described lower oxygen levels in the umbilical vein using MRI in fetuses with a severe CHD 21 . Fetuses with a CHD, however, do not appear to have smaller placental volumes 37 . In our study we excluded pregnancies complicated by placental dysfunction and found no evidence that AC growth is restricted in fetuses with a severe CHD, nor that AC growth is influenced by the type of CHD.
An important limitation is that data on long-term neurodevelopmental outcome are not available in our cohort. With regard to implications for parental counseling, these data would be highly informative. It is known that children with a severe CHD are at risk for ND, and previous studies have suggested that prenatal (head) growth restriction in CHD fetuses might be associated with ND 21, 25 . In our opinion, a clear relationship of the prenatal (neurodevelopmental) factors with long-term neurodevelopmental outcome has, however, not been established firmly so far 27, 33, 38, 39 . Large case-control studies with prenatal factors correlating to neurodevelopmental outcome are necessary.
In conclusion, fetuses with diminished ascending aorta oxygen saturation, but mainly fetuses with ToF, appear to have a slightly smaller HC at 20 weeks of gestation, and HC growth with advancing GA is restricted in all types of CHD. The cause of these findings remains elusive. In the instances in which there were (statistically) significant differences in HC, measurements were still within normal range, raising the question of its clinical significance. Based on our findings, we propose to refrain from including possible prenatal indicators, such as reduced HC, in parental counseling for neurodevelopmental outcomes so far or as a rationale for fetal therapy 40 , until a clear correlation with ND has been ascertained 41 .
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